Taylor Carolyn E.
SEC Form 4 insider trading activity
Taylor Carolyn E. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 15, 2026.
On the most recent filing, Taylor Carolyn E. is listed as Director at Tonix Pharmaceuticals Holding Corp. Inside the rolling window, Taylor Carolyn E. reported 1 open-market purchase totaling $15K in TNXP and no open-market sales.
Companies traded
Other insiders at TNXP
Insider Buying
$15K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Taylor Carolyn E. made?
Taylor Carolyn E. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Taylor Carolyn E. trade?
Taylor Carolyn E. has filed SEC Form 4 disclosures for 1 company, including TNXP.
When was Taylor Carolyn E.'s most recent SEC Form 4 filing?
Taylor Carolyn E.'s most recent SEC Form 4 filing on Tracefour is dated Jun 15, 2026.
What is Taylor Carolyn E.'s total buy and sell value in the current window?
Inside the rolling retention window, Taylor Carolyn E. bought $15K and sold $0 based on SEC Form 4 filings.
What was Taylor Carolyn E.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,415 TNXP shares on 2026-06-12, worth $15K, per SEC Form 4 filings.